China’s Ad5-nCoV COVID-19 Vaccine Granted Conditional Marketing Authorization
This week, the China National Medical Products Administration (NMPA) granted conditional marketing authorization of Recombinant COVID-19 Vaccine (Adenovirus Type 5 […]
Mexico Secures COVID-19 Vaccine Candidates from CanSino Biologics & Others Via COVAX
Mexico was active recently in the investigational vaccine market, securing two deals with two different companies for a total of […]
CanSino Biologics Inks Deal with Malaysian Holding Company to Prepare Commercialization & Distribution of Ad5-nCoV COVID-19 Vaccine
Indonesia is preparing to support the commercialization of CanSino Biologics’ Ad5-nCoV vaccine candidate as Solution Biologics Sdn Bhd (SOLBIO), a […]
China & Canada Political Tension Likely the Culprit: COVID-19 Vaccine Trial Terminated
Canada has finally made the call to terminate the CanSino Biologics Ad5-nCoV clinical trial, the nation’s first such study targeting […]
Canada Continues to Wait for its Negotiated COVID-19 Vaccine Candidate: Still ‘Stuck’ in Chinese Customs
Although TrialSite has already reported that the Canadian government has gone to a “Plan B” for COVID-19 vaccines, the issue […]
Russian Petrovax Embraces Ad5-nCoV & Brings into Russia for Phase 3 Clinical Trials
www.petrocax.com, a Russian pharmaceutical company has inked a deal with CanSino Biologics (CanSinoBIO) to drive Phase 3 clinical trials in Russia. The […]
China National Biotec Group Ramps up Phase 3 COVID-19 Vaccine Trials in Peru & Morocco While Top 10 Rich Nations Place Their Orders
The China National Biotec Group Co. (CNBG) announced its commencing Phase 3 clinical trials of its COVID-19 vaccines in both […]
The Middle East Ramps up COVID-19 Vaccine Clinical Trials and Ongoing Research & Development
The COVID-19 vaccine race moved full throttle into the Middle East and North Africa (MENA) region as trial sites in […]
Canada Implements Plan B: Embraces Project LightSpeed Securing Access to BNT162 & Mitigating Risk Associated with Ad5-nCoV
Canada made the timely move to strike a deal with the Project Lightspeed sponsors Pfizer and BioNTech SE to diversity […]
China Continues to Delay Investigational Vaccine Product to Canada: Trudeau Should Consider Plan B
The Canadian government is showing patience and tenacity sticking with Chinese vaccine partner CanSino Biologics, despite the fact that even […]
